Cleared Traditional

K920049 - MEDIX PC-305 NEONATAL INCUBATOR

K920049 is the FDA 510(k) clearance for MEDIX PC-305 NEONATAL INCUBATOR by Medix I.C.S.A.. It is a Class 2 General Hospital device (product code FMZ) cleared through the Traditional 510(k) pathway after a 501-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1993
Decision
501d
Days
Class 2
Risk

K920049 is an FDA 510(k) clearance for the MEDIX PC-305 NEONATAL INCUBATOR. Classified as Incubator, Neonatal (product code FMZ), Class II - Special Controls.

Submitted by Medix I.C.S.A. (San Martin, Buenos Aires, AR). The FDA issued a Cleared decision on May 21, 1993 after a review of 501 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5400 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Medix I.C.S.A. devices

Submission Details

510(k) Number K920049 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 06, 1992
Decision Date May 21, 1993
Days to Decision 501 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
372d slower than avg
Panel avg: 129d · This submission: 501d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMZ Incubator, Neonatal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMZ Incubator, Neonatal

All 30
Devices cleared under the same product code (FMZ) and FDA review panel - the closest regulatory comparables to K920049.
OHMEDA-OHIO CARE PLUS INCUBATOR
K974349 · Ohmeda Medical · Feb 1998
OHMEDA-OHIO CAE PLUS INCUBATOR
K962806 · Ohmeda Medical · Sep 1996
OHIO CARE PLUS INCUBATOR
K943360 · Ohmeda Medical · Sep 1994
OHIO CARE PLUS INCUBATOR
K914487 · Ohmeda Medical · Dec 1991
OHMEDA - OHIO CAR PLUS INCUBATOR, MODIFICATION
K913154 · Ohmeda Medical · Sep 1991
OHMEDA - OHIO(R) CARE PLUS INCUBATOR
K901585 · Ohmeda Medical · Jun 1990